FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:595-596 August 31, 1995 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

To the Editor: Inaccuracies in our paper "Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy"¹ prompted a careful review. On the basis of our reanalysis and an interim review by a standing faculty committee of the Harvard Medical School, we submitted a revised Table 1, published as a correction notice.² The final review of this committee concluded that ambiguities in method, presentation, and conclusions should be clarified and that errors remained that should be corrected.

In our original description of the assessment of outcomes, we never stated that lesions were measured; however, the use of the terms "dimensions" in the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• CAO, R., FARNEBO, J., KURIMOTO, M., CAO, Y. (1999). Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J. 13: 2195-2202 [Abstract] [Full Text]